先进定量流程揭示临床前多发性骨髓瘤新的空间与时间肿瘤特征
本研究开发了一种半自动PET/CT定量流程,靶向小鼠骨骼内定义的感兴趣区,并在免疫健全的骨骼播散性多发性骨髓瘤小鼠模型中纵向应用。结果显示肿瘤负荷优先定位于关节附近骨骼区域,植入后第18天脊柱、左右股骨、骨盆及骨盆关节和骶骨SUVmean显著升高,雌性小鼠后期髋关节附近骨丢失更明显。
要点
- 基于CT的精确对齐(DICE=0.966±0.005)可检测早期疾病进展和侵袭性表型。
- 植入后第18天脊柱(p=0.012)、左/右股骨(p=0.007/0.006)、骨盆及骨盆关节(p=0.018)和骶骨(p=0.02)SUVmean显著增加。
- 雌性小鼠后期髋关节附近骨丢失更明显,第25天(p=0.008)和第32天(p=0.002)HUmean显著降低。
核心结论
- 该流程能够从纵向PET/CT扫描中实现可重复、解剖精确的骨髓瘤进展区域特异性趋势定量,包括关节特异性病变趋向性和性别差异。
- 通过减轻排泄伪影和小鼠体位不一致等常见挑战,该方法克服了人工分析的局限性,并增强了对骨受累癌症临床前模型中肿瘤生物学和治疗反应的评估。
研究设计与样本
- 研究开发了一种半自动PET/CT定量流程,靶向骨髓丰富的小鼠骨骼内定义的感兴趣区,实现亚器官空间分辨率,包括骨盆等解剖复杂部位。
- 该流程应用于免疫健全的骨骼播散性多发性骨髓瘤小鼠模型的纵向分子PET研究。
- 训练了Attention U-Net从2D CT切片分割胸腰段脊柱、骨盆及骨盆关节、骶骨和股骨;使用自定义算法掩蔽生理性排泄的溢出信号,并采用基于PCA的投影沿骨骼轴映射肿瘤分布。
- 定量指标包括PET的平均和最大标准化摄取值(SUVmean、SUVmax)以及CT的Hounsfield单位(HU),用以评估肿瘤负荷、时空肿瘤分布和骨受累。
主要发现
- 肿瘤负荷优先定位于关节附近骨骼区域。
- 使用基于CT的精确对齐(DICE=0.966±0.005),检测到早期疾病进展和侵袭性表型。
- 植入后第18天观察到肿瘤摄取显著增加,脊柱SUVmean显著增加(p=0.012),左/右股骨SUVmean显著增加(p=0.007/0.006),骨盆及骨盆关节SUVmean显著增加(p=0.018),骶骨SUVmean显著增加(p=0.02)。
- 识别出性别差异:雌性小鼠后期髋关节附近骨丢失更明显,第25天(p=0.008)和第32天(p=0.002)HUmean显著降低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiological imaging plays an indispensable role in both preclinical and clinical studies of multiple myeloma (MM). However, manual quantification in longitudinal small animal PET/CT is limited by annotator bias, signal artifacts from urinary/fecal excretion, and voxel misalignment due to non-rigid registration. To address these challenges and improve characterization of tumor biology, we developed a semi-automated PET/CT quantification pipeline targeting defined regions of interest (ROIs) within the bone marrow-rich mouse skeleton, achieving sub-organ spatial resolution, including in anatomically complex sites such as the pelvis. We applied this MM-specific preclinical pipeline to analyze tumor distribution in a longitudinal molecular PET study using an immunocompetent mouse model of skeletally disseminated MM. An Attention U-Net was trained to segment the thoracolumbar spine, pelvis and pelvic joints, sacrum, and femurs from 2D CT slices. A custom algorithm masked spillover signal from physiological excretion, and a PCA-based projection was used to map tumor distribution along the skeletal axis. Quantification metrics included mean and maximum standardized uptake values (SUVmean, SUVmax) from PET and Hounsfield Units (HU) from CT to assess tumor burden, spatiotemporal tumor distribution, and bone involvement. RESULTS: Tumor burden localized preferentially to skeletal regions near joints. Using precise CT-based alignment (DICE = 0.966 ± 0.005), we detected early disease progression and aggressive phenotypes. A marked increase in tumor uptake was observed by day 18 post-implantation, with significant SUVmean increases in the spine (p = 0.012), left/right femurs (p = 0.007/0.006), pelvis and pelvic joints (p = 0.018), and sacrum (p = 0.02). Notably, sex-based differences were identified: female mice showed greater bone loss near the hip joint at later stages, with significant HUmean reductions at days 25 (p = 0.008) and 32 (p = 0.002). CONCLUSIONS: This pipeline enables reproducible, anatomically precise quantification of region-specific trends in MM progression, including joint-specific lesion tropism and sex-based differences, from longitudinal PET/CT scans. By mitigating common challenges such as excretion artifacts and inconsistent mouse positioning, our approach overcomes limitations of manual analysis and enhances evaluation of tumor biology and treatment response in preclinical models of bone-involved cancers.
引用
- Sun Z, Godbe JM, Zheleznyak A, et al. Advanced quantification pipeline reveals new spatial and temporal tumor characteristics in preclinical multiple myeloma. EJNMMI Res. 2025. PMID: 40742503. doi:10.1186/s13550-025-01291-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。